ChemicalBook > CAS DataBase List >  Alpelisib (BYL719)

Alpelisib (BYL719)

Product Name
Alpelisib (BYL719)
CAS No.
1217486-61-7
Chemical Name
Alpelisib (BYL719)
Synonyms
Alpelisib;Piqray;BYL-719;100803;CS-614;BLV-719;BYL-719 /BYL719;Alpelisib (BYL719);BYL-719(Alpelisib);Alpelisib (BLY-719
CBNumber
CB52604234
Molecular Formula
C19H22F3N5O2S
Formula Weight
441.47
MOL File
1217486-61-7.mol
More
Less

Alpelisib (BYL719) Property

Density 
1.391
storage temp. 
Store at -20°C
solubility 
≥22.07 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH
form 
White solid.
pka
6.29±0.70(Predicted)
InChIKey
STUWGJZDJHPWGZ-LBPRGKRZSA-N
SMILES
N1(C(NC2=NC(C)=C(C3C=CN=C(C(C)(C)C(F)(F)F)C=3)S2)=O)CCC[C@H]1C(N)=O
More
Less

Safety

HS Code 
29341000
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Danger
Hazard statements

H373May cause damage to organs through prolonged or repeated exposure

Precautionary statements

P260Do not breathe dust/fume/gas/mist/vapours/spray.

P314Get medical advice/attention if you feel unwell.

P501Dispose of contents/container to..…

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
16986
Product name
BYL719
Purity
≥98%
Packaging
5mg
Price
$54
Updated
2024/03/01
Cayman Chemical
Product number
16986
Product name
BYL719
Purity
≥98%
Packaging
10mg
Price
$98
Updated
2024/03/01
Cayman Chemical
Product number
16986
Product name
BYL719
Purity
≥98%
Packaging
25mg
Price
$207
Updated
2024/03/01
TRC
Product number
M331055
Product name
(2S)-N1-[4-Methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-1,2-pyrrolidinedicarboxamide
Packaging
25mg
Price
$190
Updated
2021/12/16
ApexBio Technology
Product number
A8346
Product name
BYL-719
Packaging
20mg
Price
$200
Updated
2021/12/16
More
Less

Alpelisib (BYL719) Chemical Properties,Usage,Production

Description

BYL719 is an inhibitor of phosphoinositide 3-kinase α (PI3Kα; IC50s = 4.6, 4, and 4.8 nM for wild-type, E545K mutant, and H1047R mutant PI3K, respectively). It is selective for PI3Kα over PI3Kβ, PI3Kδ, PI3Kγ, and PI4Kβ (IC50s = 1,156, 290, 250, and 581 nM, respectively), as well as VPS34, mTOR, DNA-PK, and ATR (IC50s = >9,100 nM for all). BYL719 (12.5, 25, and 50 mg/kg) reduces tumor volume in a PI3Kα-dependent Rat1-myr-p110α mouse xenograft model. It also reduces tumor burden in THP-1 acute myeloid leukemia (AML) and MCF-7 breast cancer mouse xenograft models. Formulations containing BYL719 have been used in the treatment of advanced or metastatic breast cancer.

Uses

(2S)-N1-[4-Methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-1,2-pyrrolidinedicarboxamide is a newly developed phosphatidylinositol-3-kinase (PI3K) inhibitor and a mTOR inhibitor for the treatment of proliferative diseases.

Uses

(2S)-N1-[4-Methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-1,2-pyrrolidinedicarboxamide is a newly developed phosphatidylinositol-3-kinase (PI3K) inhibitor and a mTOR inhibit or for the treatment of proliferative diseases.

Definition

ChEBI: (2S)-N1-[4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)-4-pyridinyl]-2-thiazolyl]pyrrolidine-1,2-dicarboxamide is a proline derivative.

target

PI3Kα

References

1. furet p, guagnano v, fairhurst ra et al. discovery of nvp-byl719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation. bioorg med chem lett 2013; 23: 3741-3748. 2. azab f, vali s, abraham j et al. pi3kca plays a major role in multiple myeloma and its inhibition with byl719 decreases proliferation, synergizes with other therapies and overcomes stroma-induced resistance. br j haematol 2014; 165: 89-101. 3. juric d, argiles g, burris h et al. phase i study of byl719, an alpha-specific pi3k inhibitor, in patients with pik3ca mutant advanced solid tumors: preliminary efficacy and safety in patients with pik3ca mutant er-positive (er+) metastatic breast cancer (mbc). cancer res 2012; 72: p6-10.

Alpelisib (BYL719) Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Alpelisib (BYL719) Suppliers

Shandong Jirun Biomedical Technology Co., Ltd.
Tel
0539-0539-8613587 17661611089
Fax
qq2639273505
Email
2639273505@qq.com
Country
China
ProdList
161
Advantage
58
Shanghai YuanQi Biotechnology Co., Ltd.
Tel
+86-2332782371 +86-18120098618
Email
sales@adobechem.com
Country
China
ProdList
1250
Advantage
50
Jinan shenlikang chemical technology co. LTD
Tel
0531-86092839 13153040268
Fax
QQ:2425815073
Email
2425815073@qq.com
Country
China
ProdList
248
Advantage
58
Jinan chenghui-shuangda chemical co.,ltd.
Tel
13256107535
Email
mahaiyan1123@126.com
Country
China
ProdList
117
Advantage
58
TargetMol Chemicals Inc.
Tel
021-33632979 15002134094
Fax
021-33632979
Email
marketing@targetmol.com
Country
China
ProdList
7934
Advantage
58
Shanghai Boyle Chemical Co., Ltd.
Tel
Fax
86-21-57758967
Email
sales@boylechem.com
Country
China
ProdList
2923
Advantage
55
J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Fax
86-10-82849933
Email
jkinfo@jkchemical.com
Country
China
ProdList
96815
Advantage
76
Chembest Research Laboratories Limited
Tel
021-20908456
Fax
021-58180499
Email
sales@BioChemBest.com
Country
China
ProdList
6011
Advantage
61
Nanjing Chemlin Chemical Co., Ltd
Tel
025-83697070
Fax
+86-25-83453306
Email
info@chemlin.com.cn
Country
China
ProdList
17988
Advantage
64
Shanghai Hanhong Scientific Co.,Ltd.
Tel
021-54306202 13764082696;
Email
info@hanhongsci.com
Country
China
ProdList
42982
Advantage
64
More
Less

View Lastest Price from Alpelisib (BYL719) manufacturers

Shaanxi Dideu Medichem Co. Ltd
Product
(2S)-N1-[4-Methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-1,2-pyrrolidinedicarboxamide 1217486-61-7
Price
US $1.10/g
Min. Order
1g
Purity
99.0% min
Supply Ability
100 tons min
Release date
2021-04-30
Zibo Hangyu Biotechnology Development Co., Ltd
Product
Alpelisib (BYL719) 1217486-61-7
Price
US $50.00-500.00/kg
Min. Order
10kg
Purity
0.99
Supply Ability
20tons
Release date
2023-10-30
WUHAN FORTUNA CHEMICAL CO., LTD
Product
Alpelisib 1217486-61-7
Price
US $0.00/G
Min. Order
1G
Purity
98%min
Supply Ability
30kg/month
Release date
2023-02-08

1217486-61-7, Alpelisib (BYL719)Related Search:


  • (2S)-N1-[4-Methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-1,2-pyrrolidinedicarboxamide
  • BYL-719
  • BYL-719 /BYL719
  • Alpelisib
  • BLV-719
  • (S)-N1-(4-Methyl-5-(2-(1,1,1-trifluoro-2-Methylpropan-2-yl)pyridin-4-yl)thiazol-2-yl)pyrrolidine-1,2-dicarboxaMide
  • ALPELISIB;BYL-719; BYL 719
  • CS-614
  • Alpelisib - NVP-BYL719 | BYL-719
  • 100803
  • (2S)-1-N-[4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide
  • 1,2-Pyrrolidinedicarboxamide, N1-[4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-, (2S)-
  • Alpelisib (BYL719)
  • (2S)-N1-[4-Methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-1,2-pyrrolidinedicarboxamide BYL-719
  • BYL-719 (2S)-N1-[4-Methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-1,2-pyrrolidinedicarboxamide
  • BYL-719(Alpelisib)
  • (S)-N1-(4-Methyl-5-(2-(1,1,1-trifluoro-2-methylpropan-2-yl)-pyridin-4-yl)thiazol-2-yl)pyrrolid
  • Alpelisib, 98%, a potent and selective PI3Kα inhibitor
  • (2S)-N1-[4-Methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-1,2-pyrrolidinedicarboxamide ISO 9001:2015 REACH
  • Alpelisib (BLY-719
  • Piqray
  • (2S)-N1-[4-Methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-1,2-pyrrolidine
  • Inhibitor,Phosphoinositide 3-kinase,PI3K,Alpelisib,inhibit,phosphorylation,p110α,cancer,BYL 719,antineoplastic,AKT,metastasis,mutant,BYL719,PIK3CA,breast
  • Biopterin Impurity 2
  • (2S) - N1- [4-methyl-5- [2- (2,2,2-trifluoro-1,1-dimethylethyl) -4-pyridyl] -2-thiazolyl] -1,2-pyrrolidine dicarboxylamide
  • 1217486-61-7
  • C19H22F3N5O2S
  • Inhibitors
  • Akt
  • mTOR
  • PI3K
  • Api
  • PI3K/Akt/mTOR
  • API